Alyeska Investment Group
ACGN

Alyeska Investment Group’s Aceragen Inc ACGN Stock Holding History

Alyeska Investment Group’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,966
Closed -$1.24M – 548
2018
Q1 		$1.24M Sell
4,966
-45
-0.9% -$12.3K 0.01% 380
2017
Q4 		$1.44M Buy
5,011
+331
+7% +$94.5K 0.01% 361
2017
Q3 		$1.42M Buy
4,680
+84
+2% +$22K 0.01% 397
2017
Q2 		$1.07M Sell
4,596
-1,869
-29% -$489K 0.01% 401
2017
Q1 		$2.17M Sell
6,465
-1,566
-19% -$378K 0.02% 395
2016
Q4 		$1.64M Buy
8,031
+1,548
+24% +$369K 0.01% 403
2016
Q3 		$2.25M Buy
6,483
+258
+4% +$68.2K 0.02% 380
2016
Q2 		$1.29M Buy
6,225
+126
+2% +$27.8K 0.01% 376
2016
Q1 		$1.64M Buy
6,099
+1,198
+24% +$320K 0.02% 343
2015
Q4 		$2.06M Sell
4,901
-3,376
-41% -$1.51M 0.02% 305
2015
Q3 		$3.77M Buy
8,277
+758
+10% +$335K 0.04% 282
2015
Q2 		$3.79M Buy
7,519
+121
+2% +$55.5K 0.04% 298
2015
Q1 		$3.73M Buy
+7,398
New +$4.51M 0.05% 312

Other funds holding ACGN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group's ACGN Position: Q2 2018 in Review

Alyeska Investment Group sold out of Aceragen Inc (ACGN) in Q2 2018, closing a stake of 4,966 shares — an estimated $1.24M sold.

Alyeska Investment Group first reported a position in ACGN in Q1 2015 and held it in 13 quarters. The position peaked at $3.79M in Q2 2015. 93 funds tracked by Wall St. Rank hold ACGN as of Q2 2018.

  • Alyeska Investment Group reported no remaining Aceragen Inc position as of Q2 2018 after selling out during the quarter.
  • Alyeska Investment Group sold 4,966 Aceragen Inc shares in Q2 2018, an estimated $1.24M.
  • Alyeska Investment Group first reported a position in Aceragen Inc in Q1 2015 and held it in 13 quarters.
  • Alyeska Investment Group's Aceragen Inc position peaked at $3.79M in Q2 2015.
  • 93 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2018.

Based on Alyeska Investment Group's 13F filing for Q2 2018, filed 14 Aug 2018.